Open | - |
Close | - |
Volume / Avg. | 0 / 1.921M |
Day Range | - - - |
52 Wk Range | 0.116 - 1.520 |
Market Cap | $2.263M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 45 |
Short Interest | % |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Sonoma Pharmaceuticals (NASDAQ: SNOA) through any online brokerage.
Other companies in Sonoma Pharmaceuticals’s space includes: Processa Pharma (NASDAQ:PCSA), 60 Degrees (NASDAQ:SXTP), Akanda (NASDAQ:AKAN), Jaguar Health (NASDAQ:JAGX) and Palisade Bio (NASDAQ:PALI).
The latest price target for Sonoma Pharmaceuticals (NASDAQ: SNOA) was reported by Ladenburg Thalmann on Tuesday, September 5, 2023. The analyst firm set a price target for 3.25 expecting SNOA to rise to within 12 months (a possible 2141.38% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Sonoma Pharmaceuticals (NASDAQ: SNOA) is $0.145 last updated March 18, 2024 at 7:12 PM EDT.
There are no upcoming dividends for Sonoma Pharmaceuticals.
Sonoma Pharmaceuticals’s Q3 earnings are confirmed for Thursday, February 8, 2024.
There is no upcoming split for Sonoma Pharmaceuticals.
Sonoma Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.